Bio Innovation Conference | Speakers
page-template,page-template-all-speakers,page-template-all-speakers-php,page,page-id-16863,page-parent,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive



Sally Allain, MSc., MBA- Head of JLABS @ Washington, DC, Johnson & Johnson Innovation – JLABS
Stephen Auvil- Executive Vice President, Programs, Maryland Technology Development Corp. (TEDCO)
Subhendu Basu Ph.D.- Chief Operating Officer, Adaptive Phage Therapeutics
Christy Blake- Special Projects Manager, Montgomery County [MD] Economic Development Corporation (MCEDC)
Ernesto Chanona- Senior Manager, Office of BioHealth and Life Sciences, Maryland Department of Commerce
Walter Copan, Ph.D.- Under Secretary of Commerce for Standards and Technology and NIST Director
Michael Ehret- Director of Business Development, ASELL
Bill Enright- CEO, Vaccitech
Marian Ewell, Sc.D.- Chief Scientific Innovations Officer, The Emmes Company
Steven M. Ferguson, CLP- NIH Office of Tech Transfer
Michael Fitzpatrick, Ph.D.- President, Cellphire Inc.
John A. Fraser, CLP, RTTP- Assoc. VP, Research (Ret), Florida State University; Past President, AUTM
Jeff Galvin- Founder and Chief Executive Officer, American Gene Technologies
Angela Graham- President and CEO, Quality Biological
The Honorable Jim Greenwood- Former President and CEO, Biotechnology Innovation Organization (BIO)
William Hearl, Ph.D.- Founder and CEO, Immunomic Therapeutics, Inc.
John P. Holden- Director of Economic Development and Tourism, Stafford County Va.
Senator Chris Van Hollen- Senator of Maryland
Ellen Hukkelhoven, Ph.D.- Managing Director, Perceptive Advisors
Syed Husain- Senior Vice President, CDMO Business Unit Head, Emergent BioSolutions
David Ihrie- Chief Technology Officer, Center for Innovative Technology (CIT)
Murat Kalayoglu, M.D., Ph.D.- President and CEO, Cartesian Therapeutics, Inc.
Kazem Kazempour, Ph.D.- President and CEO, Amarex Clinical Research
Rachel King- Co-Founder and CEO, GlycoMimetics, Inc.
Sean Kirk- Executive Vice President, Manufacturing and Technical Operations, Emergent BioSolutions
Claire Leurent, Ph.D., MBA- Principal, Venture Investments, Johnson & Johnson Innovation
Geoffrey Ling- Founding Partner and Chief Operating Officer, On Demand Pharmaceuticals
Ken Mills- President and CEO, REGENXBIO, Inc.
Helen Montag- Senior Director, Corporate Partnerships, Johns Hopkins Technology Ventures
Sally Mossman, Ph.D.- VP, Head of R&D Center, US, GSK Vaccines
Randy Ribaudo, Ph.D.- Co-Founder of SciPhD; and ex-NIH and ex-Celera
Martin Rosendale- Chief Executive Officer, Maryland Life Sciences
Jon Rowley, Ph.D.- Founder and Chief Product Officer, RoosterBio
Linda Segal- Principal, The McCormick Group
Tom Spitznagel- Senior Vice President, BioPharmaceutical Development and Manufacturing, Macrogenics
Rebecca A. Styn, Ph.D.- Erie Management Group, Director of Community Investment, Erie, Pa.
John Trizzino- Executive Vice President, Chief Business Officer and Chief Financial Officer, Novavax
Rosemarie Truman- Founder and CEO, The Center for Advancing Innovation
Gayatri Varma- Director, Transactions, Business Development & Licensing, AstraZeneca
Aaron Vernon- Vice President, Engineering & Supply Chain, Autolus
Thomas Weithman- Center for Innovative Technology (CIT), Managing Director and Vice President
Robel Worku- Economic Development Specialist, Montgomery County Economic Development Corporation